Is SCYX or SNOA more undervalued in 2026?

CirclFi compares SCYNEXIS, Inc. (SCYX) and Sonoma Pharmaceuticals, Inc. (SNOA) using 13 institutional-grade valuation models. SCYX has a Quality of Company score of 5.6/10 while SNOA scores 5.4/10.

Which is a better buy — SCYX or SNOA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do SCYX and SNOA valuations compare?

SCYX at $0.74 and SNOA at $1.11 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

SCYX vs SNOA Valuation Comparison 2026 — Intrinsic Value Analysis

SCYX

Drug Manufacturers - Specialty & Generic

SCYNEXIS, Inc.

Quality

5.6

out of 10

Value Trap

LOW

Price

$0.74

Last close

Models

10/13

Active

SNOA

Drug Manufacturers - Specialty & Generic

Sonoma Pharmaceuticals, Inc.

Quality

5.4

out of 10

Value Trap

LOW

Price

$1.11

Last close

Models

8/13

Active

Model-by-Model Comparison

Model	Type	SCYX Fair Value	SCYX Upside	SNOA Fair Value	SNOA Upside
Bayesian DCF	Intrinsic	$0.39	-47.4%	$0.67	-39.9%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$1.11	+56.6%	$0.69	-35.9%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$0.84	+14.8%	$3.26	+193.6%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for SCYX vs SNOA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

SCYX vs SNOA — Which Stock Is More Undervalued?

SCYX scores higher with a 5.6/10 quality rating vs SNOA's 5.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing SCYNEXIS, Inc. (SCYX) and Sonoma Pharmaceuticals, Inc. (SNOA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

SCYX currently trades at $0.74 with a QOC of 5.6/10, while SNOA trades at $1.11 with a QOC of 5.4/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).